TrialBMC musculoskeletal disorders2017

Leflunomide is equally efficacious and safe compared to low dose rituximab in refractory rheumatoid arthritis given in combination with methotrexate: results from a randomized double blind controlled clinical trial.

Harindu Wijesinghe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.